Publication:
Role of myocyte enhancing factor 2B in epithelial myofibroblast transition of human gingival keratinocytes

dc.contributor.authorQiang Sunen_US
dc.contributor.authorApsorn Sattayakhomen_US
dc.contributor.authorJohannes Backsen_US
dc.contributor.authorWolfgang Stremmelen_US
dc.contributor.authorWalee Chamulitraten_US
dc.contributor.otherForschungsgruppenen_US
dc.contributor.otherUniversitatsklinikum Mannheimen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherDepartment of Internal Medicine III (Cardiology)en_US
dc.date.accessioned2018-06-11T04:39:31Z
dc.date.available2018-06-11T04:39:31Z
dc.date.issued2012-02-01en_US
dc.description.abstractIt has recently emerged that the myogenic contribution of the epithelial mesenchymal transition plays a role in neoplastic invasion and metastasis. Myocyte enhancing factor 2B (MEF2B) is the only MEF2 isoform expressed during early embryonic development, and is herein proposed to transactivate the downstream target proteins of the epithelial myofibroblast transition (EMyT). We have previously generated eight preneoplastic cell lines with spindle and cobblestone morphology from human gingival mucosal keratinocytes immortalized by E6/E7 of human papillomavirus type 16. Spindle cells formed tubulogenic morphogenesis on Matrigel and exhibited contractility, anchorage-independent growth and invasiveness to a greater extent than cobblestone cells. Expression of MEF2B mRNA and myofibroblast proteins was higher in spindle cells compared with cobblestone cells. Epidermal growth factor (EGF) treatment of cobblestone cells also induced expression of these genes. Knockdown of MEF2B in a cobblestone cell line abolished EGF-induced upregulation of MEF2, vimentin and non-muscle caldesmon proteins, but enhanced basal expression of mesenchymal vimentin and fibronectin. Differential regulation of intermediate filaments revealed an unrecognized role of MEF2B in myogenic transformation of the epithelial to a myofibroblast phenotype, which occurs as epithelioid variants in some soft tissue sarcomas. © 2012 by the Society for Experimental Biology and Medicine.en_US
dc.identifier.citationExperimental Biology and Medicine. Vol.237, No.2 (2012), 178-185en_US
dc.identifier.doi10.1258/ebm.2011.011261en_US
dc.identifier.issn15353699en_US
dc.identifier.issn15353702en_US
dc.identifier.other2-s2.0-84857339916en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/13811
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84857339916&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleRole of myocyte enhancing factor 2B in epithelial myofibroblast transition of human gingival keratinocytesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84857339916&origin=inwarden_US

Files

Collections